Glucocorticoid-induced Normotensive Scleroderma Renal Crisis: A Report on Two Cases and a Review of the Literature in Japan

Akihito Maruyama; Takao Nagashima; Kohei Ikenoya; Yoko Aoki; Yasushi Matsuyama; Masahiro Iwamoto; Seiji Minota

doi:10.2169/internalmedicine.52.0400

CASE REPORTS

Glucocorticoid-induced Normotensive Scleroderma Renal Crisis: A Report on Two Cases and a Review of the Literature in Japan

Akihito Maruyama, Takao Nagashima, Kohei Ikenoya, Yoko Aoki, Yasushi Matsuyama, Masahiro Iwamoto, Seiji Minota

Author information

Keywords: glucocorticoid, normotensive renal crisis, systemic sclerosis, thrombotic microangiopathy, thrombotic thrombocytopenic purpura

JOURNAL OPEN ACCESS

2013 Volume 52 Issue 16 Pages 1833-1837

DOI https://doi.org/10.2169/internalmedicine.52.0400

Details

Abstract

We herein report the findings of 2 cases of normotensive scleroderma renal crisis (SRC) that developed soon after the commencement of a glucocorticoid therapy. We also review 8 cases of normotensive SRC reported in Japan, including our cases. The common characteristics of these 8 cases are as follows: the recent onset of systemic sclerosis, the presence of diffuse skin sclerosis, the presence of myositis and/or serositis, a high titer of antinuclear antibody and positivity for anti-Scl-70 antibody. In 7 of the 8 patients, thrombotic microangiopathy developed within one month of starting the glucocorticoid treatment. We should be careful with the use of glucocorticoids in systemic sclerosis patients exhibiting these features in order to avoid cases of normotensive SRC.

Corresponding author

Register with J-STAGE for free!